Apyx Medical Corporation (APYX)

Apyx Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	29.3	31.74	43.65	10.19	30.87	41.92
Cash & Short-Term Investments	29.3	31.74	43.65	10.19	30.87	41.92
Cash Growth	-10.33%	-27.29%	328.30%	-66.98%	-26.35%	-28.73%
Accounts Receivable	11.25	15.58	14.12	10.7	13.14	8.4
Other Receivables	-	-	-	7.64	8.13	8.93
Receivables	11.25	15.58	14.12	18.35	21.26	17.33
Inventory	8.19	7.56	9.92	11.8	6.78	4.05
Prepaid Expenses	1.17	1.56	2.66	2.64	1.83	2.8
Total Current Assets	49.92	56.44	70.36	42.97	60.74	66.09
Property, Plant & Equipment	6.55	6.74	7.15	7.59	6.87	7.22
Other Long-Term Assets	1.72	1.66	1.73	1.22	1.11	0.81
Total Assets	58.19	64.84	79.24	51.78	68.72	74.11
Accounts Payable	2.89	2.62	2.71	2.67	2.63	1.51
Accrued Expenses	2.66	3.46	5.21	3.78	6.69	4.69
Current Portion of Leases	0.4	0.36	0.37	0.25	0.29	0.36
Current Unearned Revenue	1.48	0.69	0.49	0.85	0.53	-
Other Current Liabilities	3.13	3.6	3.97	4.3	3.07	2.59
Total Current Liabilities	10.57	10.72	12.74	11.85	13.21	9.15
Long-Term Debt	34.37	33.89	33.19	-	-	-
Long-Term Leases	4.32	4.52	4.95	0.54	0.02	0.31
Long-Term Unearned Revenue	1.19	1.12	1.25	1.41	1.32	0.62
Other Long-Term Liabilities	0.29	0.26	0.2	0.18	0.17	0.17
Total Liabilities	50.73	50.51	52.32	13.98	14.71	10.25
Common Stock	0.04	0.04	0.04	0.04	0.03	0.03
Additional Paid-In Capital	93.05	92.08	81.11	73.28	66.22	61.07
Retained Earnings	-85.84	-77.91	-54.45	-35.74	-12.55	2.62
Total Common Equity	7.25	14.21	26.7	37.58	53.7	63.72
Minority Interest	0.2	0.13	0.22	0.21	0.31	0.14
Shareholders' Equity	7.46	14.34	26.92	37.79	54.01	63.86
Total Liabilities & Equity	58.19	64.84	79.24	51.78	68.72	74.11
Total Debt	39.08	38.76	38.5	0.8	0.31	0.68
Net Cash (Debt)	-9.78	-7.02	5.15	9.4	30.57	41.24
Net Cash Growth	-	-	-45.18%	-69.26%	-25.88%	-28.50%
Net Cash Per Share	-0.25	-0.20	0.15	0.27	0.89	1.21
Filing Date Shares Outstanding	37.82	37.79	34.64	34.6	34.43	34.32
Total Common Shares Outstanding	37.79	37.79	34.64	34.6	34.41	34.29
Working Capital	39.35	45.72	57.62	31.12	47.53	56.94
Book Value Per Share	0.19	0.38	0.77	1.09	1.56	1.86
Tangible Book Value	7.25	14.21	26.7	37.58	53.7	63.72
Tangible Book Value Per Share	0.19	0.38	0.77	1.09	1.56	1.86
Land	-	-	-	1.6	1.6	1.6
Buildings	-	-	-	4.43	4.43	4.45
Machinery	-	5.06	4.83	5.09	5.04	4.72
Construction In Progress	-	0.64	0.4	0.51	0.65	0.42
Leasehold Improvements	-	0.28	0.21	0.18	0.17	0.16

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q